1. Home
  2. PDS vs VIR Comparison

PDS vs VIR Comparison

Compare PDS & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Drilling Corporation

PDS

Precision Drilling Corporation

HOLD

Current Price

$68.27

Market Cap

918.1M

Sector

N/A

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.14

Market Cap

773.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDS
VIR
Founded
1951
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
918.1M
773.5M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PDS
VIR
Price
$68.27
$6.14
Analyst Decision
Buy
Strong Buy
Analyst Count
2
11
Target Price
$99.00
$25.73
AVG Volume (30 Days)
87.8K
1.9M
Earning Date
10-22-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.98
N/A
Revenue
$1,316,232,437.00
$16,860,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.89
$48.05
P/E Ratio
$21.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.20
$4.16
52 Week High
$71.77
$14.45

Technical Indicators

Market Signals
Indicator
PDS
VIR
Relative Strength Index (RSI) 65.44 49.04
Support Level $66.44 $6.49
Resistance Level $71.77 $6.75
Average True Range (ATR) 2.12 0.48
MACD -0.01 -0.04
Stochastic Oscillator 70.82 44.41

Price Performance

Historical Comparison
PDS
VIR

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: